Dennis Ausiello
Nephrology · Boston, MANPI 1316938962
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,530,866 of the $4,579,138 with a category attached, or 98.9%. Alnylam Pharmaceuticals Inc. accounts for 68.3% of it on its own, with 2 other manufacturers making up the rest. Among nephrology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $25,725 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$3.1M
- Pfizer$1.4M
- Seres Therapeutics, Inc.$38K
What the payments were for
- Consulting fees$4,530,86699%
- Travel & lodging$39,1901%
- Food & beverage$6,5820%
- Gifts$2,5000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 90 | $3,128,732 |
| Pfizer | 85 | $1,412,906 |
| Seres Therapeutics, Inc. | 3 | $37,500 |
How this compares
$4,579,138 in reported general payments places this provider in the 95th percentile of 339 nephrology providers in Massachusetts.
Other nephrology in Boston
- David FriedmanBoston$19.8M
- Martin PollakBoston$19.8M
- Ajay SinghBoston$916K
- Leslie FangBoston$388K
- Jean FrancisBoston$244K
- Joseph BonventreBoston$175K
- Andrew AllegrettiBoston$139K
- Ravi ThadhaniBoston$115K
- Meghan SiseBoston$113K
- Ronald PerroneBoston$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.